This brief segment summarizes an important randomized trial in which people with knee osteoarthritis fared just as well with nonsurgical treatments such as pain killers and physical therapy as they did when they received these treatments plus arthroscopic surgery. The study confirms findings from an earlier sham-controlled trial showing that people with osteoarthritis of the knee were no better after arthroscopic surgery than after sham surgery.
The segment covers some of this essential information, but not all. Missing are mention of the costs of treatment, which are substantial–and arguably the driving force behind the study; the harms of treatment, which appear to be few and rarely serious; and the fact that people randomized to receive surgery also received nonsurgical treatments.
The newscast also overstates the trial’s conclusions. In an attempt to explain precisely who the findings apply to, it cites an orthopaedic surgeon who wrote the editorial that accompanied the new study. He says that many people who have arthritis “have other problems such as a torn meniscus or a loose piece of cartilage in the knee who may be helped by arthroscopic surgery.” What is the evidence to support this statement? Is it based on findings from a high-quality randomized trial—or the same type of observational evidence that for so long led people to believe arthroscopy was beneficial for arthritis? (Answer: To our knowledge, the latter.) The study’s authors say their findings to not support this view. They write, “Although some may argue that treatment is beneficial for patients with mechanical symptoms of catching or locking or those with early [osteoarthritis]”—i.e., patients with symptoms attributed to meniscal tears or stray bits of “cartilage”—“prespecified subgroup analyses also failed to show efficacy in this population of patients.” The investigators go on to remind readers that their trial intentionally excluded people with large meniscal tears (known as “bucket handle” tears), “in whom arthroscopic surgery is considered an effective intervention.” Note that the researchers do not say that arthroscopy is “proven” to be effective even in these people.
The researchers’ well-designed and carefully executed trial attempts to answer a very important but specific question. This segment both under-informs and misinforms viewers about its meaning.
The story says that arthroscopy to treat knee osteoarthritis is “not worth the expense or risk,” but it fails to mention what the costs are either to the individual or the community. Costs are substantial, and arguably the driving force behind the study. To ignore them is a significant oversight.
The newscast accurately states that arthroscopy is usually not helpful for people with knee osteoarthritis. It does not mention the duration of the trial (2 years) or the outcome measured (a validated arthritis assessment score).
Moreover, one of the physicians interviewed in the story appears to overstate the findings. He suggests that arthroscopy may be beneficial for people whose only problem is a tear of the meniscus. The study’s authors specifically address this view, and suggest that it may not be true. They write, “Although some may argue that treatment is beneficial for patients with mechanical symptoms of catching or locking or those with early [osteoarthritis]”—i.e., patients with symptoms attributed to meniscal tears—“prespecified subgroup analyses also failed to show efficacy in this population of patients.” They go on to point out that their trial intentionally excluded people with large meniscal tears (known as bucket handle tears), “in whom arthroscopic surgery is considered an effective intervention.” Note that they do not say that arthroscopy is “proven” to be effective even in these people.
Viewers hear the word “risk” once during the newscast—in the closing line of the story. But the story says nothing about the seriousness or frequency of the risks. Fortunately, risks appear to be few and serious problems rare.
The newscast explains the key study design facts—that this is a randomized, controlled trial. However, in saying that the researchers randomized people “to either receive the surgery or just physical therapy and pain relievers,” it fails to adequately describe the treatments. Those who had surgery also received the nonsurgical treatments, an important design feature.
The newscast does not exaggerate the importance of knee osteoarthritis, a widespread and often disabling condition.
The newscast cites two sources—a coauthor of the new trial and an independent source with no apparent conflict of interest.
The story describes some of the nonsurgical strategies (physical therapy and pain relievers) used to treat knee osteoarthritis, although the amount of detail is quite limited.
It’s clear from the newscast that knee arthroscopy, performed “almost a million times a year,” is widely available.
The newscast makes it clear that this treatment has been around a while, and studied before.
There is no obvious use of text from the press release.
Systematic, Criteria-Driven
We’ve written about the hype of liquid biopsies for years (see link in comment below). And now this…. https://www.statnews.com/2022/01/12/medicare-shouldnt-cover-liquid-biopsies-early-cancer-detection/
Case counts still matter. “(There) are stories that may not be told adequately if only hospitalizations and deaths are emphasized.” @garyschwitzer interviewed by @dbauder of @AP. https://apnews.com/article/omicron-changing-news-outlets-covid-data-da9272f7c4c8a109c3bfb56bed9e9c76
My friend Gary @garyschwitzer wrote to his city council representative in a Minnesota town about a Viva Las Vegas event scheduled for January.
The response he got seems to perfectly capture where we are now.
https://www.healthnewsreview.org/2021/12/2021-ends-with-covid-craziness-in-sports-and-politics/
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.